LPHHF yields 1818.18% · JNJ yields 2.13%● Live data
📍 LPHHF pulled ahead of the other in Year 1
Combined, LPHHF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LPHHF + JNJ for your $10,000?
Logan Group Company Limited, an investment holding company, operates as an integrated property developer in the People's Republic of China. It operates through four segments: Property Development, Development Management, Urban Redevelopment, and Property Operation. The Property Development segment develops and sells residential and commercial properties, retail shops, and office units; and sells land held for development. The Development Management segment constructs office premises and residential buildings; and provides decoration services to external customers and interior decoration services to property buyers. The Urban Redevelopment Business segment sells land and properties for urban redevelopment. The Property Operation segment leases office units, commercial centers, retail shops, and hotels. The company was formerly known as Logan Property Holdings Company Limited and changed its name to Logan Group Company Limited in June 2020. The company was founded in 1996 and is headquartered in Shenzhen, the People's Republic of China. Logan Group Company Limited is a subsidiary of Junxi Investments Limited.
Full LPHHF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.